Gonococcal Acute Septic Arthritis in Immunocompetent Patients by Kalo, T. et al.
Advances in Life Science and Technology                                                                                                 www.iiste.org 
ISSN 2224-7181 (Paper) ISSN 2225-062X (Online) 
Vol.69, 2018 
 
14 
Gonococcal Acute Septic Arthritis in Immunocompetent Patients 
 
T. Kalo1      R. Celami2      E. Puca3      E. Muça3      N. Gjermeni3      Sh. Kurti3       E. Qyra3 
Dh. Kraja3      E. Rapushi4      M. Hoxha5      S. Damo6      M. Eqimi7 
1Profesor of Infectious Disease, Service of Infectious Diseases, University Hospital Center “Mother Theresa”, 
Tirana, Albania 
2Profesor of Obstetrics and Gynecology, Chief of Gynecology Service, Elbasan Regional Hospital, Hospital 
privileges as Obstetrician and Gynecologist at American Hospital of Tirana,  Professor and Chief of TM-I 
Department at Faculty of Medical Techical Sciences, University of Aldent, Tirana, Albania 
3 Physician at Service of Infectious Diseases, University Hospital Center “Mother Theresa”, Tirana, Albania 
4Physician at Service of Rheumatology, University Hospital Center “Mother Theresa”, Tirana, Albania 
5Physician at Service of Allergology and Immunology, University Hospital Center “Mother Theresa”, Tirana, 
Albania 
6 Physician at Service of Neonatology, Qeen Geraldine University Hospital of Obstetrics Gynecology, Tirana, 
Albania 
7 Physician at American Hospital, Tirana, Albania 
Corresponding author Rustem Celami, MD, PhD, Associated Profesor 
 
Abstract 
The objective of this study is to estimate the clinical evolution and the biological values and of three cases 
suffering from Gonococcal acute septic arthritis (GASA).Our study is based in a thoroughfully screening of 18 
patients hospitalized in our service during the period of time of March 2011 – July 2016. Among those 18 cases, 
12 of them (66.7%) were diagnosed with Acute Septic Arthritis (ASA) due to Staphylococcus aureus, 3 cases 
(16.65%) were diagnosed with ASA due to Neisseria gonorrhoeae, and 3 other cases (16.65%) were diagnosed 
with ASA due to Streptococcus pneumoniae, Escherichia coli and Echinella corrodens. Two sexually active 
women at the seventh and tenth day of an untreated suppurative cervico-vaginitis and one man at the eighth day 
of an untreated suppurative urethritis were consulted at the Service of Infectious Diseases of University Hospital 
Center “Mother Theresa”, because of: severe pains in left wrist, in the left elbow and in the right knee, swollen 
of those articulation, difficulties in their movements, shivering and a high fever of   38-39.2ºC. Neisseria 
gonorrhea was insolated in three cases in blood cultures and cervical/urethral samples and they were sensitive 
towards Cyclines, Cephalosporins and Fluoroquinolones. All three patients were immunocompetent. 
Keywords: Neisseria gonorrhea, Acute Septic Arthritis, Biological values.  
 
Introduction 
Neisseria gonorrhoeae is the most common sexually transmitted bacteria causing infective arthritis. In nowadays 
the Gonococcal infection may be poised to become more troublesome because of Fluoroquinolones, Ceftriaxone 
and other antibiotics resistance is increasing, and many contemporary physicians are unfamiliar with 
musculoskeletal manifestations of Neisseria gonorrhoeae infections.  Gonococcal arthritis represents the most 
common cause of inflammatory monoarthritis in young adults. If it is left untreated a disseminated gonococcal 
infection (DGI), which occurs in up to 3% of cases, it may results in several complications, such as: Gonorrheal 
endocarditis, Gonorrheal meningitis and Gonorrheal arthritis (GA), which is caused by the growth of the 
gonococcus in joints’ fluids, most commonly wrists, knees and ankles, and this occurs hopefully in only 1% of 
cases. ). The elapsed time between the initial gonococcal infection and the DGI may vary from 1 day until 3 
months. GA manifests as either a bacteremic infection (arthritis-dermatitis syndrome, 60% of cases), or as a 
localized septic arthritis (remaining 40%). (1, 4, 5, 6, 8, 9) 
 
Methodology and Results:   
Our study is based in a thoroughfully screening of 18 patients hospitalized in our Service of Infectious Diseases 
of University Hospital Center “Mother Theresa”, during the period of time of March 2011 – July 2016. Among 
those 18 cases, 12 of them (66.7%) were diagnosed with Acute Septic Arthritis (ASA) due to Staphylococcus 
aureus, 3 cases (16.65%) were diagnosed with ASA due to Neisseria gonorrhoeae, and 3 other cases (16.65%) 
were diagnosed with ASA due to Streptococcus pneumoniae, Escherichia coli and Echinella corrodens Two 
sexually active women at the seventh and tenth day of an untreated suppurative cervico-vaginitis and one man at 
the eighth day of an untreated suppurative urethritis were consulted at the because of: severe pains in left wrist, 
in the left elbow and in the right knee, swollen of those articulation, difficulties in their movements, shivering 
and a high fever of   38-39.2ºC. Septic arthritis was localized in the left wrist and in the left elbow (1st and 2nd 
case in female persons), as well as in the right knee (3rd case in a male person). We observed an inflammatory 
painful edema; fluctuation in palpation of the above-mentioned articulations, as well as a purulent liquid was 
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aspirated from them. All those three elements were compatible of an acute suppurative arthritis (ASA). Plain 
radiography findings of the affected joints were normal. 
Neisseria gonorrhea was insolated in three cases in blood cultures and cervical/urethral samples and they were 
sensitive towards Cyclines, Cephalosporins and Fluoroquinolones. All three patients were immunocompetent. 
The following phenomena have been noticed on the laboratory data of blood samples during the first week of 
manifestation of GASA: WBC was 21,400/mcL (normal range 4,500-10,000/mcL, Fibrinogen level was 
731mg/d (normal range 200-400 mg/dL), PCR was 61. 7mg/L (normal level is <0.5mg/L), ALP was 198 IU/LT 
(normal range is 44-147 IU/L).  
Patients were also tested also other sexually transmitted infections such as  HIV, Hepatitis B, Chlamydia, 
Syphilis and the results were negative. 
The treatment was based in the sensitivity of insolated germs and it was as following: Ciprofloxacin: 200 
mg x 3 IV for the first three days plus 1 gr of Azithromycin in single dose, followed by oral Ciprofloxacin 750 
mg x 2 for 7 days (the first case), and Cefuroxim: 750 mg x 3 IV for the first three days plus 1 gr of 
Azithromycin in single dose, followed by oral Cefuroxim of 500 mg x 2 for 7 days. 
The outcome of GASA after the intensive anti-gonococcal and supportive therapy was excellent for all of 
them, and we haven’t observed any functional sequele after six months of their ambulatory follow-up.   
    
Figure 1, 2 and 3: Left wrist, left elbow and right knee.  
 
Discussion 
Gonorrhea is the second most commonly reported notifiable disease in the United States, with 350,062 cases 
reported in 2014. The sexually transmitted diseases are typically underreported, however the Centers for Disease 
Control and Prevention (CDC) estimates that approximately 820,000 cases of gonorrhea occur yearly in the US. 
(2, 3) 
The most recent 2008 WHO Report, estimates that they have documented a 21% global increase in the total 
number of new cases of gonorrhoeae in adults compared with 2005, with an estimated 106 million adults being 
infected with N. gonorrhea in 2008. The incidence of gonococcal infection is lower in Europe than in North 
America. (13)  
Gonococcal arthritis is caused by infection with the gram-negative diplococcus N gonorrhoeae, a highly 
infectious organism capable of colonizing diverse mucosal surfaces. Common sites of infection include the 
urethra, cervix, pharynx and rectum, but infection may be asymptomatic in some patients. Hematogenous spread 
of the mucosal infection occurs in 0.5-3% of cases, and disseminated infection is thought to play a major role in 
the pathogenesis of gonococcal arthritis. Patients with Disseminated Gonococcal Infection (DGI), may present 
with dermatitis-arthritis syndrome (60% of cases) or with a localized septic arthritis (40%). These presentations 
may represent different phases of a disease continuum. Unlike Staphylococcus aureus septic arthritis, gonococcal 
arthritis is rarely associated with joint destruction. (1, 4, 5, 6, 8, 9) 
Patients may experience pain, redness, and swelling in 1 joint (or sometimes multiple joints), most 
commonly in a knee, wrist, ankle, or elbow. Joint symptoms begin within days to weeks of gonococcal infection. 
For patients with septic arthritis resulting from gonococcal infection, proper antibiotic treatment and joint 
drainage typically leads to full recovery. (4, 9)   
Most patients with suspected acute infectious arthritis, including gonococcal arthritis, should be 
hospitalized to establish a diagnosis and to monitor for improvement or complications. The empiric antibiotics 
directed against likely pathogens should be used until confirmatory laboratory data are available. Antibiotic 
coverage in healthy hosts should initially include gram-positive organisms, which account for approximately 
80% of non-gonococcal monoarthritis cases (Staphylococcus aureus, 60%; non–group A Streptococcus species, 
15%; S pneumoniae, 3%). Gram-negative organisms (18%) should be covered in patients who are 
immunocompromised, elderly, or otherwise at risk. The transition to oral antibiotics can usually be made 24-48 
hours after clinical improvement. (1, 5, 6, 8) 
It is recently observed higher rates of infection due to the increase of antimicrobial-resistant gonococci. If 
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trends continue, researchers say there is a very real possibility that some strains of Neisseria gonorrhea may 
become resistant to all current treatment options. As of right now, the current drug of choice is either Ceftriaxone 
or Cefixime. Although these two drugs are still very effective they are already showing signs of resistance, 
especially to Cefixime. If this problem of resistance to medication is not resolved, there is a real possibility that 
gonorrhea will be a very difficult infection to treat. Gonococcal infection in HIV-positive patients is treated with 
the same regimen used for the general population. (3, 7, 10, 11, 12) 
Ceftriaxone is the drug of choice for disseminated gonococcal infection, pelvic inflammatory disease, and 
pharyngeal infection. It is the second-line agent for uncomplicated genitourinary infections, but only because of 
higher cost, along with the discomfort and additional administration expense of injection. Although 
cephalosporins remain an effective treatment for gonococcal infections, the CDC has reported that resistance to 
Cefixime increased from 0.2% in 2000 to 1.4% in 2010, and resistance to Ceftriaxone increased from 0.1% to 
0.3% in 2010 during that period. (3, 7, 11) 
Ten percent to thirty percent of people with gonococcal infection are co-infected with Chlamydia. Thus, 
routine dual therapy with Doxycycline and Azithromycin has been recommended and shown to be cost effective. 
Dual therapy also decreases the development of antimicrobial resistance in bacteria. (11) 
Because of resistance to oral cephalosporins in the United States, there is only one first-line regimen, which 
is dual treatment with Ceftriaxone and Azithromycin. In addition, persons infected with Neisseria gonorrhoeae 
frequently are coinfected with Chlamydia trachomatis; this finding has led to the longstanding recommendation 
that persons treated for gonococcal infection also be treated with a regimen that is effective against 
uncomplicated genital C trachomatis infection, further supporting the use of dual therapy that includes 
Azithromycin. (7, 11) 
The 2015 CDC recommendations for disseminated gonococcal infection are: 
• Ceftriaxone 1 g IM/IV every 24 h plus a single dose of Azithromycin 1 g PO  
• Alternative regimen - Cefotaxime 1 g IV every 8 h plus a single dose of Azithromycin 1 g PO  
When treating for the arthritis-dermatitis syndrome, the clinician can switch to an oral agent, with the choice 
guided by antimicrobial susceptibility testing, 24-48 h after substantial clinical improvement. The total treatment 
course should be at least 7 days. (7) 
In conclusion: Early diagnosis and treatment of a disseminated gonococcal infection (DGI) and of a gonococcal 
acute septic arthritis (GASA), give more chances to the patient for a better outcome of disease. Leukocytosis, 
Elevated levels of Fibrinogen, PCR and ALP are the common biological features in GASA. They have the same 
significance for the GASA’s outcome as they have for its diagnosis. 
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